Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE In addition, the A alleles in CHRNA3 rs1051730 and CHRNA5 rs16969968 were associated with the risk for LC (OR = 1.66, P = 0.07 and OR = 1.57, P = 0.1, respectively) and for COPD (OR = 2.04, P = 0.01 and OR = 1.91, P = 0.02, respectively). 29993116

2018

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE Studies link a gene cluster encoding for α3β4α5-D398N nicotinic acetylcholine receptors to lung cancer risk as well as link a second mutation in this cluster to an increased risk for nicotine dependence. 28045487

2017

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE SNP rs16969968 as a Strong Predictor of Nicotine Dependence and Lung Cancer Risk in a North Indian Population 29172281

2017

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE The potential association of three polymorphisms in the CHRNA3 (rs1051730(G > A)), CHRNA5 (rs16969968(G > A)), and AGPHD1 (rs8034191(A > G)) with the lung cancer risk has been widely investigated, but the results are inconsistent. 27072204

2016

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE These results: 1) underscore the potential value of smoking cessation for all smokers, 2) suggest that CHRNA5 rs16969968 genotype affects lung cancer diagnosis through its effects on smoking, and 3) have potential value for framing preventive interventions for those who smoke. 27543155

2016

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE Given the existing evidence that this CHRNA5 variant predicts favorable response to cessation pharmacotherapy, these findings underscore the potential clinical and public health importance of rs16969968 in CHRNA5 in relation to smoking cessation success and lung cancer risk. 25873736

2015

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE Accordingly, rs588765-rs16969968 may be a genetic marker to lung cancer risk, even among never-smokers. 26282330

2015

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE Our meta-analysis provided statistical evidence for a strong association between rs16969968 polymorphism and the risk of lung cancer, especially in smokers and Caucasians. 26434895

2015

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE Further, these results suggest that the association between rs16969968 and lung cancer may be mediated by the quantity of smoke inhaled. 23358500

2014

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE No association with lung cancer risk was found for CHRNA5 rs16969968. 23178447

2013

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE Our results also confirm and extend previous findings for associations between rs16969968 and lung cancer, loss of lung function equivalent to that of COPD, and smoking quantity. 23443019

2013

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE The A allele of the SNP rs16969968 (alpha5, G>A), which correlates with the development of lung cancer, shows a non-significant trend to be associated with cervical lesions. 22406075

2012

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE Additional SNP associations were observed on 15q25.1 in genes previously associated with lung cancer, including a missense variant in CHRNA5 (rs16969968: OR = 1.60, 95% CI = 1.27-2.01, P = 5.9 x 10-5). 23232035

2012

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE A rare variant of chromosomal region 15q25.1, marked by rs16969968 (substitution 1354G>A in CHRNA5), was found to be associated with increased lung cancer and nicotine-dependence risk. 21955800

2012

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE The increase in cotinine levels indicated an increased risk of lung cancer with each additional copy of the rs1051730-rs16969968 risk allele (per-allele odds ratio = 1.31, 95% CI = 1.21 to 1.42). 22534784

2012

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE However, rs7452888 (6q27) was identified as a possible candidate SNP to influence lung cancer survival, while stratified analysis hinted at a possible role for rs8034191, rs16969968 (15q25.1) and rs4324798 (6p22.1) in influencing survival time in lun</span>g cancer patients who were never-smokers, based on a small sample. 21750227

2011

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE The rs16969968-lung cancer association did not differ by intake level of most dietary factors examined, but was stronger for individuals diagnosed at < 70 years of age or having a baseline smoking history of <40 cigarette pack-years. 21229299

2011

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE Two variants in the nicotinic acetylcholine receptor subunit genes CHRNA5 and CHRNA3 on 15q25, rs16969968 and rs578776, were associated with cotinine (P = 0.001 and 0.03, respectively) in current smokers and with lung cancer risk (P < 0.001 and P = 0.001, respectively). 21862624

2011

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE Diplotype analysis of rs3841324 with either rs16969968 or rs8034191 showed that these polymorphisms influenced the lung cancer risk independently. 22028403

2011

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE In models adjusting for cigarettes-per-day, we confirm the association between rs16969968 and lung cancer (p<10(-20)) and observe a nominally significant association with COPD (p = 0.01); the other loci are not significantly associated with either lung cancer or COPD after adjusting for rs16969968. 20700436

2010

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE A four-SNP haplotype spanning CHRNA5 (rs11637635 C, rs17408276 T, rs16969968 G) and CHRNA3 (rs578776 G) was associated with increased lung cancer risk (P = 0.002). 20587604

2010

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE Recently, to identify genetic factors that modify lung cancer risk, CHRNA5 non-synonymous variant amino acid position 398 (D398N) was identified. 19577767

2010

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE Associations between 15q25 and the risk of lung cancer were replicated in white ever-smokers (rs16969968: odds ratio [OR] = 1.26, 95% confidence interval [CI] = 1.21 to 1.32, P(trend) = 2 x 10(-26)), and this association was stronger for those diagnosed at younger ages. 20548021

2010

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE We performed a detailed analysis of one 15q single nucleotide polymorphism (SNP) (rs16969968) with smoking behaviour and cancer risk in a total of 17 300 subjects from five LC studies and four upper aerodigestive tract (UADT) cancer studies. 19776245

2010

dbSNP: rs16969968
rs16969968
0.100 GeneticVariation BEFREE We conclude that there are at least two distinct mechanisms conferring risk for nicotine dependence and lung cancer: altered receptor function caused by a D398N amino acid variant in CHRNA5 (rs16969968) and variability in CHRNA5 mRNA expression. 19443489

2009